Related Experiment Video
Updated: Mar 28, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Why do patients participate in long-term cardiovascular trials?--a questionnaire-based study
Helena Dellborg1, Görel Hultsberg-Olsson1, Mikael Dellborg1,2
1a Research Unit, Department of Medicine/Östra , Sahlgrenska University Hospital/Östra , Gothenburg , Sweden ;
Insights
Patients in cardiovascular clinical trials value continuous care from familiar doctors and nurses. Altruistic motives, like advancing science, also significantly drive participation in these long-term studies.
Area of Science:
- Cardiology
- Clinical Research
- Patient Engagement
Background:
- Patient participation is crucial for developing new cardiovascular disease treatments.
- Long-term clinical trials require high patient retention to yield valid results.
- Understanding patient motivations can improve trial recruitment and reduce dropout rates.
Purpose of the Study:
- To identify key motivators for patient participation and retention in long-term cardiovascular clinical trials.
- To inform strategies for enhancing patient enrollment and adherence in clinical research.
Main Methods:
- A questionnaire with 11 statements was administered to 135 participants in cardiovascular clinical trials.
- Participants' reasons for joining and remaining in trials were assessed.
- Demographic data including age and gender were collected.
Main Results:
- The primary motivator for participation was consistent access to their doctor and nurse (66%).
- A strong secondary motivator was the desire to advance scientific knowledge (55%).
- Free visits were the least significant factor influencing participation.
Conclusions:
- Continuous care and a familiar healthcare team are significant drivers for patient involvement in cardiovascular trials.
- Altruistic motivations, such as contributing to scientific progress, are equally important for patient retention.
- Addressing these motivators can enhance patient recruitment and long-term commitment in clinical research.
Introduction:
Participation in clinical trials by patients with cardiovascular disease is paramount to the development of new treatments. Capturing and keeping patients in the trials until the end is very important and trials are often of long duration and include patients in a clinically stable condition, with few symptoms and a low risk of recurrent disease. We investigated what motivates patients to participate in long-term cardiovascular trials. Increased knowledge may enhance inclusion and retention and minimize lost to follow-up or withdrawal of consent.
Materials And Methods:
A questionnaire with 11 statements to elucidate the reasons for participation and retention in long-term clinical trials was used and replies from 135 participants in trials, 78% men, mean age was 68 years.
Results:
The two most important reasons for participation were: "I am able to see the same doctor and nurse at the visits", indicated by 89 patients (66%), followed by "I want to promote science", which was indicated by 74 patients (55%). The least important reason was "The visits are free of cost".
Conclusion:
Patients who participate in cardiovascular clinical trials do so because it may provide access to more continuous care but equally important are altruistic motives including a wish to promote science.
Related Concept Videos
Longitudinal Studies
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials: Overview
Longitudinal Research
Clinical Trials
There are four phases in a clinical trial. A phase one...

